-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - factors in predicting the
risk of AF recurrence (e.g., age, gender, body mass index, hypertension, diabetes … who received RFA as a second-line therapy
(i.e., patients who did not respond to medical
therapy) … alone (net
difference between the two treatments, +1 to +25
favoring RFA). … catheter
ablation
of
atrial
fibrillation:
the
impact
of
periprocedural
therapeutic … alone
(net
difference
between
the
two
treatments,
+1
to
+25
favoring
-
effectivehealthcare.ahrq.gov/sites/default/files/interventions-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … have a major impact on patient management if there
are fewer unplanned ED visits and fewer emergency treatments … Adherence
to long-term therapies.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
September 23, 2010 - Background
The 2009 systematic literature review “Treatments of Common Hip Fractures” was
conducted … Of the top seven
ranked research questions, only three, treatments for frail elderly patients and the … Collaborators
NCT01051830
(ClinicalTrials.gov)
Care model for hip fractured elderly
persons with diabetes … researchers with broad hip fracture
outcomes and rehabilitation interests were added, including physical therapy … NCT01051830 Care model for hip
fracture patient with diabetes
(Taiwan)
C-3
Key Question/Cross-cutting
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
June 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … No effective treatments are available to
improve long-term nutritional absorption other than intestinal … Bethesda (MD): National Institute of
Diabetes and Digestive and Kidney Diseases
(NIDDK), National
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
October 07, 2011 - It is nowhere
near long enough to assess diabetes, cardiovascular events or
mortality. … research is needed
to determine whether or not there are true differences within the ACEI
and ARB therapeutic … exist that demonstrates that both
losartan and valsartan lower the incidence of new onset Type II
diabetes … literature underscores the notion that “class
effect” may not occur consistently and that individual treatments … As BIPI’s own research and development
in this therapeutic area continues, we will work to ensure that
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-214-afib-disposition-comments.pdf
October 30, 2019 - predicting stroke and
bleeding risk in persons with AFib, and
comparative effectiveness of a variety of therapies … The “as
treated” (treatment received)
analysis compares the actually
received treatments. … do not seem like clear labels,
since both are active treatments. … We have separated the tables
out as to whether the patients
are on therapy or not, the
specific therapies … We have expanded this section
to include information on the
various treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
March 21, 2016 - increasing age, female sex,
chronic diarrhea, nerve damage (from injury, multiple
sclerosis, or chronic diabetes … We edited the
statement to read: Treatments for FI are
imperfect and treatment combinations are
common … Treatments for FI
are imperfect and treatment combinations are
common. … Combination therapy with biofeedback, loperamide, and
stool-bulking agents is effective for the treatment … engaging patients in a conversation about risks
and benefits of each therapeutic option is important
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/accountable-care-registries-guide-3rd-ed-addendum-white-paper-2018-5.pdf
January 01, 2018 - These systems
contain detailed clinical data about patient care and may be useful for understanding treatment … is that the HIE
agreement between provider organizations must include not only use of the data for treatment … the prior year.10,11
Examining subpopulations such as those with multiple conditions and expensive treatments … and administration of intravenous medications including chemotherapy
and physical or occupational therapy … Information on specific care plans, such as,
physical therapy for a certain number of weeks or a schedule
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
May 01, 2023 - criteria that define
malnutrition, (2) variability of nutrition interventions (from medical nutrition therapy … current evidence for the effectiveness
of providing nutrition interventions before or during cancer therapy … While studies addressing Key Questions (KQs) 1-3 enrolled individuals from multiple
cancer types, treatments … Assessment of Body
Composition as an Indicator of Early
Peripheral Parenteral Nutrition Therapy in … nutrition on the
nutritional status and blood glucose in
patients with gastric cancer complicated
with diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_research-protocol.pdf
November 24, 2014 - increases the likelihood of chronic conditions such as obesity, smoking,
sedentary lifestyles, diabetes … , cognitive therapy, cognitive behavioral
therapy, interpersonal therapy, psychodynamic therapies, and … other talk therapies. … The efficacy of light therapy in the
treatment of mood disorders: a review and meta-analysis of the … just SGAs
and nonpharmacological
therapies, they include
all of the treatment
comparisons of KQ1
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
January 01, 2022 - Physiotherapy (n=45); core stability-based physiotherapy treatment; two sessions of therapy per week … Physiotherapy (n=36); core stability-based physiotherapy treatment; two sessions of therapy per week … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence … therapy referral. … physical therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Menopausal Symptoms: Comparative Effectiveness of Therapies. … that most times, the authors mean “menopausal hormone therapy”
when they say “hormone therapy.” … 5, 2015
20
Commentator
& Affiliation Section Comment Response
Why not include mention of diabetes … risk with hormone therapy use? … Diabetes was not an outcome selected for inclusion.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
February 02, 2022 - s likelihood of being screened for medical
risk factors such as high blood pressure, preeclampsia, diabetes … /eclampsia, and
postpartum venous thrombosis), onset of new
conditions (such as hypertension and
diabetes … ), emergency room visits, need for
and diabetes), emergency room visits,
need for rehospitalization … congruent care,
e.g., providers not taking
cultural preferences or
differences into account in
treatment … of
chronic disease
● Pre-pregnancy
and pregnancy
cardiovascular
risk factors
(hypertension,
diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
February 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … predominantly symptom-
management options; however, emerging research aims to identify disease-modifying therapies … AD pathogenesis, leading researchers to investigate intranasally delivered insulin as a
potential therapy … Food and Drug
Administration (FDA) for treating diabetes, including Humulin® and Humulin R® (Eli Lilly … Intranasal
insulin therapy for Alzheimer disease and
amnestic mild cognitive impairment: a pilot
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment-future_research.pdf
September 01, 2012 - First,
this area of research – the use of breathing techniques and even complementary and alternative
therapies … agenda related to the use of breathing techniques and exercises and other
complementary and alternative therapies … Kuwait:
Dasman Diabetes Institute; 2012.
http://clinicaltrials.gov/ct2/show/NCT01509
443. … Heart rate variability
biofeedback: its role in asthma therapeutics. … research, new-to-the-field thinking
o Relevance to asthma: potential for new insights into causes
and treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/saturated-fat-replacement-protocol.pdf
January 01, 2024 - lowering medications)
o Overweight/obese
o Hyperglycemia and related
conditions, including type 2 diabetes … o Race/ethnicity
o Physical activity level
o Anthropometry
o Health status, including type 2
diabetes … studies, any change in
outcome measure must exclude data
from the first week after end of any prior
treatments … All subgroup analyses or other evaluations of heterogeneity of
treatment effect will be extracted. … Dietary fats and mortality among patients with type 2 diabetes:
analysis in two population based cohort
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
April 11, 2011 - Measuring BP to diagnose hypertension and monitor therapy is problematic. … treatment-related hypotension. … o Adherence to hypertension treatment. … We will use separate forms for
questions related to treatment (KQs 1–4) and predictors (KQ 5). … We will extract basic demographic data such as age, sex, and race; diabetes, cardiovascular
disease,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-evidence-summary-health-equity.pdf
January 01, 2020 - research on achieving health equity
in 10 preventive services for cancer, cardiovascular
disease, and diabetes … Abnormal blood glucose and type 2 diabetes
screening
Adults age 40 to 70 years who are
overweight … Abbreviations: BMI = body mass index; EHR = electronic health record; NRT = nicotine replacement
therapy … trials indicated improved quit rates with patient
navigation, counseling, and nicotine replacement
therapy … Unequal Treatment:
Confronting Racial and Ethnic Disparities in Health
Care.
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … and nasal spray bottles.44,46,47 Various insulin products
already approved for use in patients with diabetes … They
thought that the drug’s well-known safety profile and long history of use (in diabetes) would … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
March 16, 2017 - living with limb loss, a number
expected to double by 2050 mostly due to the rising prevalence of diabetes … community ambulator who has the ability to traverse most environmental barriers
and may have vocational, therapeutic … Current level of function
o Etiology of amputation
o Time since amputation
o Comorbidities (e.g., diabetes … “Projection of the year
2050 burden of diabetes in the US adult population: Dynamic modeling of incidence … “Preservation-Amputation Care and Treatment (PACT)
Program.” In: Affairs DoV, editor.